MEDIFAST INC — Director's Dealing 2022

May 11, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2022-05-05

Reporting Person: Chard Daniel R (Director, Chairman & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-05-05	Common Stock	P	431.078	$183.25	Acquired	108598.352	Indirect

Footnotes

F1: The shares were acquired by The Dan and Allyson Family Irrevocable Trust, for which the reporting person is Settlor of the Trust and Investment Trustee, pursuant to a broker-sponsored Dividend Reinvestment Plan.

F2: These shares are directly owned by The Dan and Allyson Family Irrevocable Trust, for which the reporting person is the Settlor of the Trust and Investment Trustee.